Serum GDNF levels and anxiety disorders in a population-based study of young adults.

CONCLUSION: In this paper, we observed increased serum levels of GDNF in individuals with anxiety disorders, suggesting that this biomarker can be used as a putative marker for AD's. The knowledge of the physiological changes related to anxiety disorders can provide a better understanding of AD's pathogenesis, as well as, mechanisms involved in the progression of this condition. PMID: 29906418 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29906418?dopt=Abstract

Source: International Journal of Clinical Chemistry - June 12, 2018 Category: Chemistry Authors: Moreira FP, Wiener CD, Jansen K, Portela LV, Lara DR, de Mattos Souza LD, da Silva RA, Oses JP Tags: Clin Chim Acta Source Type: research